|
feasibility study
|
ERO_0001402 |
|
|
combinational intervention
|
OPMI_0000365 |
|
|
Clinical Trial Final Report
|
NCIT_C115575 |
|
|
investigational supplement administration
|
CTO_0000120 |
|
|
open blinded design
|
CTO_0000114 |
|
|
masking design
|
CTO_0000005 |
|
|
medical device
|
ERO_0001092 |
|
|
single blinded design
|
CTO_0000113 |
|
|
double blinded design
|
CTO_0000112 |
|
|
procedure clinical trIal
|
CTO_0000111 |
|
|
secondary outcome measurement
|
CTO_0000118 |
|
|
primary outcome measurement
|
CTO_0000117 |
|
|
single arm design
|
CTO_0000116 |
|
|
sequential design
|
CTO_0000115 |
|
|
investigational drug administration
|
CTO_0000119 |
|
|
telephone number
|
OPMI_0000112 |
|
|
country name
|
OBI_0001627 |
|
|
pivotal clinical trial
|
CTO_0000132 |
|
|
Indian clinical trials registry
|
CTO_0000011 |
|
|
other outcome measure information
|
CTO_0000010 |
|
